Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland.
Orthopaedic and Traumatological Department, University Hospital Basel, Switzerland.
Clin Microbiol Infect. 2019 Jan;25(1):76-81. doi: 10.1016/j.cmi.2018.03.040. Epub 2018 Apr 10.
Little information has been published on orthopaedic internal fixation-associated infections. We aimed to analyse time-dependent microbiology, treatment, and outcome.
Over a 10-year period, all consecutive patients with internal fixation-associated infections at the University Hospital of Basel, were prospectively followed and clinical, microbiological and outcome data were acquired. Infections were classified as early (0-2 weeks after implantation), delayed (3-10 weeks), and late (>10 weeks).
Two hundred and twenty-nine patients were included, with a median follow-up of 773 days (IQR 334-1400). Staphylococcus aureus was the most prevalent pathogen (in 96/229 patients, 41.9%). Enterobacteriaceae were frequent in early infections (13/49, 26.5%), whereas coagulase-negative staphylococci (36/92, 39.1%), anaerobes (15/92, 16.3%) and streptococci (10/92, 10.9%) increased in late revisions. Failure was observed in 27/229 (11.7%). Implants were retained in 42/49 (85.7%) in early, in 51/88 (57.9%) in delayed, and in 9/92 (9.8%) in late revisions (p < 0.01). Early revisions failed in 6/49 (12.2%), delayed in 9/88 (10.2%), and late in 11/92 (13.0%) (p 0.81). Debridement and retention failed in 6/42 (14.3%) for early, in 6/51 (11.8%) for delayed, and in 3/9 (33.3%) for late revisions (p 0.21). Biofilm-active antibiotic therapy tailored to resistance correlated with improved outcome for late revisions failure (6/72, 7.7% versus 6/12, 50.0%; p < 0.01) but not for early revisions failure (5/38, 13.2% versus 1/11, 9.1%; p 1.0).
Treatment of internal fixation-associated infections showed a high success rate of 87-90% over all time periods. Implant retention was highly successful in early and delayed infections but only limited in late infections.
有关骨科内置物相关感染的信息较少。我们旨在分析随时间变化的微生物学、治疗和结局。
在 10 年期间,巴塞尔大学医院前瞻性地连续随访所有内置物相关感染患者,获取临床、微生物学和结局数据。感染分为早期(植入后 0-2 周)、延迟(3-10 周)和晚期(>10 周)。
共纳入 229 例患者,中位随访时间为 773 天(IQR 334-1400)。金黄色葡萄球菌是最常见的病原体(229 例患者中有 96 例,41.9%)。肠杆菌科在早期感染中较为常见(49 例中有 13 例,26.5%),而凝固酶阴性葡萄球菌(36 例,39.1%)、厌氧菌(15 例,16.3%)和链球菌(10 例,10.9%)在晚期翻修中更为常见。229 例患者中有 27 例(11.7%)治疗失败。早期感染中保留了 42/49(85.7%)的植入物,延迟感染中保留了 51/88(57.9%)的植入物,晚期感染中保留了 9/92(9.8%)的植入物(p<0.01)。早期感染中有 6/49(12.2%)失败,延迟感染中有 9/88(10.2%)失败,晚期感染中有 11/92(13.0%)失败(p 0.81)。早期感染中有 6/42(14.3%)清创和保留失败,延迟感染中有 6/51(11.8%)清创和保留失败,晚期感染中有 3/9(33.3%)清创和保留失败(p 0.21)。针对耐药性进行的靶向生物膜活性抗生素治疗与晚期感染失败(6/72,7.7% 比 6/12,50.0%;p<0.01)相关,但与早期感染失败无关(5/38,13.2% 比 1/11,9.1%;p 1.0)。
所有时间段内置物相关感染的治疗成功率均较高,为 87-90%。早期和延迟感染中保留植入物的成功率很高,但晚期感染中保留植入物的成功率有限。